Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 79 | 4 | 12 | 2 | €300.60 | €331.06 | 10.134% |
| Boston Scientific | 70 | 0 | 15 | 0 | €51.35 | €102.23 | 99.081% |
| Eli Lilly Corp. | 71 | 3 | 7 | 1 | €749.80 | €992.11 | 32.316% |
| Insmed Inc. | 66 | 1 | 6 | 1 | ? | €172.10 | 51.281% |
| Intuitive Surgical Inc | 60 | 2 | 13 | 0 | €401.95 | €517.02 | 28.628% |
| Gilead Sciences Inc | 53 | 0 | 3 | 0 | €109.22 | €125.00 | 14.448% |
| HCA Holdings Inc. | 52 | 0 | 7 | 0 | €371.70 | €443.22 | 19.242% |
| Neurocrine Bioscience | 51 | 0 | 6 | 0 | €110.30 | €148.52 | 34.649% |
| Ionis Pharmaceuticals Inc. | 52 | 1 | 3 | 0 | €62.54 | €77.25 | 23.523% |
| Tenet Healthcare | 47 | 0 | 0 | 0 | €158.00 | €193.52 | 22.483% |
| Vertex Pharmaceuticals Inc. | 46 | 0 | 1 | 0 | €365.40 | €458.50 | 25.480% |
| Alnylam Pharmace. | 46 | 0 | 1 | 0 | €260.80 | €428.30 | 64.225% |
| Regeneron Pharmaceuticals Inc. | 45 | 0 | 5 | 0 | €637.00 | €705.36 | 10.731% |
| Johnson & Johnson | 45 | 1 | 12 | 0 | €192.28 | €215.99 | 12.328% |
| Dexcom Inc. | 43 | 1 | 0 | 0 | €52.40 | €77.13 | 47.195% |
| Rhythm Pharmaceuticals | 41 | 1 | 0 | 1 | ? | €109.86 | 52.578% |
| Cytokinetics Inc. | 40 | 0 | 2 | 0 | €52.66 | €71.95 | 36.624% |
| Cigna Corp. | 37 | 0 | 1 | 0 | €239.40 | €306.38 | 27.976% |
| Jazz Pharmaceuticals plc | 36 | 0 | 1 | 0 | €172.45 | €176.91 | 2.587% |
| Thermo Fisher Scientific Inc. | 34 | 0 | 6 | 0 | €399.70 | €523.69 | 31.020% |
| Acadia Pharmaceuticals | 34 | 1 | 0 | 0 | €19.38 | €28.15 | 45.302% |
| Edwards Lifesciences Corp. | 33 | 0 | 4 | 0 | €71.44 | €81.28 | 13.777% |
| Amgen Inc. | 35 | 3 | 2 | 0 | €291.00 | €312.46 | 7.373% |
| AbbVie Inc. | 30 | 0 | 2 | 0 | €168.85 | €211.50 | 25.258% |
| United Therapeutics | 30 | 1 | 4 | 0 | €484.10 | €507.66 | 4.867% |